Abstract: In an approach for storage optimization for products manufacturing, a processor pulls parts data for a set of part numbers. A processor calculates an average shelf time for each part number of the set of part numbers. A processor calculates a priority index for each part number of the set of part numbers based on the average shelf time for each part number of the set of part numbers. A processor determines a category for each part number of the set of part numbers based on the priority index for each part number of the set of part numbers and a quantity of parts cumulative percentage for each part number of the set of part numbers.

Abstract: In an approach for storage optimization for products manufacturing, a processor pulls parts data for a set of part numbers. A processor calculates an average shelf time for each part number of the set of part numbers. A processor calculates a priority index for each part number of the set of part numbers based on the average shelf time for each part number of the set of part numbers. A processor determines a category for each part number of the set of part numbers based on the priority index for each part number of the set of part numbers and a quantity of parts cumulative percentage for each part number of the set of part numbers.

Abstract: The invention relates to synergistically active veterinary compositions useful particularly for the treatment of mastitis and metritis. The invention further relates to a process for preparing these compositions. The compositions according to the invention comprise, based on 1 part by weight of 6,9,18-tris(2-aminoethyl) -15-benzyl-21-[.sup.- 2,8-bis(2-aminoethyl)-5-(1-hydroxyethyl) -15-methyl-4,7,10-trioxo-3,6,9-triazaheptadecanamido]-3-(1-hydroxyethyl)-1 2-isobutyl-1,4,7,10,13,16,19-heptaazacyclotricosane-2, 5,8,11,14,17,20-heptaone or a pharmaceutically acceptable acid addition salt thereof, 1 to 1000 parts by weight of 1-(2-chlorophenyl)-diphenylmethyl-1H-imidazole or 1 to 400 parts by weight of 2-methyl-5,7-dichloro-8-hydroxyquinoline, respectively, optionally in admixture with carriers and/or additives commonly used in the pharmaceutical industry.

Abstract: The invention relates to weight gain-increasing compositions, particularly fodder supplement, premix, drinking water supplement, bolus and/or microcapsule containing 0.001 to 90% by weight of 1-(3,5-dihydroxyphenyl)-2-(tertiary butylamino)-ethanol or a physiologically acceptable acid addition salt thereof as active ingredient in admixture with inert solid and/or liquid carrier(s).

Abstract: The invention relates to a synergistic veterinary composition and/or a fodder premix useful for preventing or curing bacterial, fungal and protozoic infection particularly occurring at poultry species. Furthermore the invention relates to a process for preparing same. The composition or premix contains 1 to 100 parts by mass of 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine and/or 1 to 100 parts by mass of 2,4-diamino-5-(3,4-dimethoxybenzyl)pyrimidine as well as 1 to 100 parts by mass of 2,6-dimethoxy-4-sulfanilamidopyrimidine or a pharmaceutically acceptable salt thereof and 1 to 100 parts by mass of 8-hydroxyquinoline or a pharmaceutically acceptable acid addition salt thereof optionally in admixture with carrier(s) and/or additive(s) commonly used in the pharmaceutical industry or for the preparation of premixes.

Abstract: The invention relates to fodder additives comprising a compound inducing the microsomal enzyme system of the liver, preferably a compound of the formula (I) ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are identical or different and stand for hydrogen, halogen, trihalomethyl, or alkyl or alkoxy each containing from 1 to 6 carbon atoms;R.sub.4 is phenyl, dialkylaminocarbonyl or alkoxycarbonyl having from 1 to 6 carbon atoms in the alkyl and alkoxy moieties, respectively;R.sub.5 is hydrogen or methyl, or together with R.sub.4 and the adjacent nitrogen atom forms a hetero-ring having up to 8 members;n is 1, 2, 3, 4 or 5;m is 0 or 1;a is 0 or 1,with the proviso that if a=0, R.sub.1 is trihalomethyl and R.sub.2 and R.sub.3 both are hydrogen, preferably in amount of 0.5 to 99% by weight, in an admixture with conventional carriers and/or additives and optionally at least one further active ingredient conventionally used in the animal husbandry.

Abstract: The invention relates to a synergistic antibiotic composition useful for the treatment of respiratory, gastrointestinal or urinary infections and septicaemia of domestic animals. The composition comprises tiamulin hydrogen fumarate and an aminoglycoside antibiotic or a pharmaceutically acceptable salt thereof in a weight ratio of 5:1 to 1:5. The active components are admixed or diluted with a carrier, used in veterinary therapy, in a weight ratio of 1:1 to 1:50 and formulated for oral or parenteral application.

Abstract: The invention relates to a pressure limiting valve, mainly for hydraulic mine props, which has a working space with an inlet opening connected to a high-pressure space and an outlet opening connected to low-pressure space in the operative position of the valve, a displaceable first valve member engageable with a valve seat within this working space in the shut-off position of the valve, a spring pressing the first valve member to the valve seat and in a given case, a spring sustaining the valve seat, suitably a gas spring and in which according to the invention the first valve member has transfer passages ensuring communication between the inlet opening and the outlet opening in the open position of the valve, as well as second valve member provided with a frustoconical head facing the cover plate and having a stem loosely fitted in a guide bore formed in the first valve member which is formed with an annular axial flange surrounding the head of the second valve member which is concentrically arranged within